BiomX (PHGE) Non Operating Investment Income (2018 - 2026)

BiomX (PHGE) posted Non Operating Investment Income of $1.9 million for Q1 2026, up 7625.86% sequentially from $24075.0 in Q1 2019.

BiomX (PHGE) Non Operating Investment Income (2018 - 2026) Analysis & Trends

BiomX has reported Non Operating Investment Income for 3 years, with the latest figure at $1.9 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non Operating Investment Income (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	BiomX	351,774.34	-816,225.66	-	1.86 Mn

Download Data